Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib
Clinical trial NCT01908426 · COMPLETED
Trial details
- NCT number
- NCT01908426
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-26
- Primary completion
- 2017-10-16
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.